» Articles » PMID: 27478588

Scaling Up Strategies of the Chronic Respiratory Disease Programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)

Overview
Publisher Wiley
Date 2016 Aug 2
PMID 27478588
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respiratory disease action plan includes (1) AIRWAYS integrated care pathways (ICPs), (2) the joint initiative between the Reference site MACVIA-LR (Contre les MAladies Chroniques pour un VIeillissement Actif) and ARIA (Allergic Rhinitis and its Impact on Asthma), (3) Commitments for Action to the European Innovation Partnership on Active and Healthy Ageing and the AIRWAYS ICPs network. It is deployed in collaboration with the World Health Organization Global Alliance against Chronic Respiratory Diseases (GARD). The European Innovation Partnership on Active and Healthy Ageing has proposed a 5-step framework for developing an individual scaling up strategy: (1) what to scale up: (1-a) databases of good practices, (1-b) assessment of viability of the scaling up of good practices, (1-c) classification of good practices for local replication and (2) how to scale up: (2-a) facilitating partnerships for scaling up, (2-b) implementation of key success factors and lessons learnt, including emerging technologies for individualised and predictive medicine. This strategy has already been applied to the chronic respiratory disease action plan of the European Innovation Partnership on Active and Healthy Ageing.

Citing Articles

Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024.

Hellings P, Conti D, Bertels X, Backer V, Brusselle G, De Corso E Front Allergy. 2025; 6:1540499.

PMID: 40065834 PMC: 11891202. DOI: 10.3389/falgy.2025.1540499.


A Herbal Prescription of Insamyangyeongtang as a Therapeutic Agent for Frailty in Elderly: A Narrative Review.

Lee H, Arai I, Kwon S Nutrients. 2024; 16(5).

PMID: 38474849 PMC: 10934365. DOI: 10.3390/nu16050721.


Self-Management in Allergic Rhinitis: Strategies, Outcomes and Integration into Clinical Care.

Ciprandi G J Asthma Allergy. 2023; 16:1087-1095.

PMID: 37818035 PMC: 10561621. DOI: 10.2147/JAA.S273478.


Reshaping the Management of Allergic Rhinitis in Primary Care: Lessons from the COVID-19 Pandemic.

Abdullah B, Snidvongs K, Poerbonegoro N, Sutikno B Int J Environ Res Public Health. 2022; 19(20).

PMID: 36294211 PMC: 9603682. DOI: 10.3390/ijerph192013632.


Probiotics in Children with Asthma.

Ciprandi G, Tosca M Children (Basel). 2022; 9(7).

PMID: 35883962 PMC: 9316460. DOI: 10.3390/children9070978.


References
1.
Franco R, Santos A, do Nascimento H, Souza-Machado C, Ponte E, Souza-Machado A . Cost-effectiveness analysis of a state funded programme for control of severe asthma. BMC Public Health. 2007; 7:82. PMC: 1896159. DOI: 10.1186/1471-2458-7-82. View

2.
Morais-Almeida M, Pite H, Pereira A, Todo-Bom A, Nunes C, Bousquet J . Prevalence and classification of rhinitis in the elderly: a nationwide survey in Portugal. Allergy. 2013; 68(9):1150-7. DOI: 10.1111/all.12207. View

3.
Bousquet J, Addis A, Adcock I, Agache I, Agusti A, Alonso A . Integrated care pathways for airway diseases (AIRWAYS-ICPs). Eur Respir J. 2014; 44(2):304-23. DOI: 10.1183/09031936.00014614. View

4.
Cruz A, Souza-Machado A, Franco R, Souza-Machado C, Ponte E, Santos P . The impact of a program for control of asthma in a low-income setting. World Allergy Organ J. 2012; 3(4):167-74. PMC: 3488909. DOI: 10.1097/WOX.0b013e3181dc3383. View

5.
Nogues M, Jeandel C, Touchon J, Pinto N, Blain H, Leglise M . [Living Lab MACVIA-LR. Frailty]. Presse Med. 2015; 44 Suppl 1:S36-46. DOI: 10.1016/j.lpm.2015.07.010. View